Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Pain. 2013 Sep 24;155(5):868–880. doi: 10.1016/j.pain.2013.09.018

Fig. 4.

Fig. 4

PCA plot of cross-correlations between cyclophosphamide cystitis-induced hypolocomotion (CPLOCO) and assays of spontaneous inflammatory nociception and inflammatory hypersensitivity. (A) CPLOCO is genetically distinct from all spontaneous inflammatory nociception assays as evidenced by the vector angles close to 90° between CPLOCO and the assays. The proportion of total variance accounted for is 0.76. (B) Similarly, CPLOCO is genetically distinct from all inflammation-induced hypersensitivity assays except zymosan-induced cold hypersensitivity assessed with acetone application (rs = 0.62 with ZYMACET). The proportion of total variance accounted for is 0.69. Font color reference is as in Fig. 2 legend.